Shivinder Mohan Singh
Shivinder Mohan Singh | |
|---|---|
| Born | India |
| Occupation | Entrepreneur |
| Years active | –2019 |
| Known for | Fortis Healthcare, Religare, Ranbaxy Laboratories |
| Notable work | Non-executive vice chairman at Fortis Healthcare |
Shivinder Mohan Singh is an Indian entrepreneur and former billionaire linked to Fortis Healthcare, Religare, and Ranbaxy Laboratories. He held the position of non-executive vice chairman at Fortis Healthcare. Presently, Singh is detained on charges of criminal breach of trust, alongside his brother Malvinder Mohan Singh, with several fraud allegations pending against them.
Early life
Singh is the son of Dr. Pravinder Singh and the grandson of Bhai Mohan Singh, who established Ranbaxy Laboratories. This company was eventually integrated into Sun Pharmaceuticals Ltd, which was formerly part of the Japanese corporation Daiichi Sankyo.
Business career
Following their father’s passing in 1999, Singh and his brother Malvinder Mohan Singh inherited a 33.5% ownership in Ranbaxy. By April 2015, they were ranked as the thirty-fifth wealthiest individuals in India, with a combined fortune estimated at $2.5 billion.
Education
Singh completed his schooling at The Doon School and obtained a BA (hons.) degree in mathematics from St. Stephen's College, Delhi. He also earned an MBA with a focus on health sector management from the Fuqua School of Business at Duke University in the United States.
Personal life
Residing in New Delhi, Singh lives with his wife Aditi S. Singh and their four sons. During the AGM of Fortis Hospitals on 24 September, he declared his resignation and handed over control of the hospital chain to his brother.
Arrest
As of 1 November 2019, both Singh brothers were held in custody, with their judicial detention extended until 14 November 2019. On 12 December 2019, a court in Delhi denied Singh’s bail application concerning accusations of fund misappropriation at Religare Finvest Limited (RFL).